자궁근종 치료 기기 시장 규모, 점유율, 동향 분석 리포트 : 테크놀러지별, 치료 모드별, 지역별, 부문별 예측(2025-2030년)

Uterine Fibroids Treatment Devices Market Growth & Trends:

The global uterine fibroids treatment devices market size is estimated to reach USD 12.1 billion by 2030, registering to grow at a CAGR of 9.4% from 2025 to 2030 according to a new report by Grand View Research, Inc. An increasing population of uterine fibroids patients and rising awareness initiatives related to fibroids diagnosis and treatment are driving the market.

Minimally invasive and non-invasive surgeries for the treatment of Uterine Fibroids (UF) are gaining popularity owing to the reduced risk associated with these procedures. Smaller incisions decrease post-operative pain and facilitate speedy recovery, thus leading to high adoption of these procedures and triggering the growth of R&D in this field. Many key players are investing in research and development for the launch of innovative minimally and non-invasive surgical instruments.

Furthermore, several awareness campaigns, new product launches, and incorporation of new technologies by market players are expected to fuel the market growth during the forecast period. For instance, companies such as Merit Medical are dedicated to spreading fibroid awareness as well as promoting a safe and effective alternative to surgery. They also provide Ask4UFE patient educational programs, such as infographics, brochures, monthly articles, and newsletters, based on uterine fibroids and the benefits of uterine fibroid embolization (UFE).

Uterine Fibroids Treatment Devices Market Report Highlights:

• The surgical techniques segment dominated the market with a revenue share of 34.0% in 2024, attributed to the increasing prevalence of uterine fibroids among women, necessitating effective surgical interventions.
• The ablation techniques segment is projected to grow at the highest CAGR of 10.4% over the forecast period.
• The invasive treatment segment dominated the market with the largest revenue share in 2024, attributed to its established efficacy in treating severe uterine fibroids.
• North America uterine fibroids treatment devices market dominated the global market, with a revenue share of 48.2% in 2024, driven by high healthcare spending and advanced medical infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Technology
  • 1.2.2. Mode of Treatment
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Uterine Fibroids Treatment Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Uterine Fibroids Treatment Devices Market: Technology Business Analysis

• 4.1. Technology Market Share, 2024 & 2030
• 4.2. Technology Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Billion)
• 4.4. Surgical Techniques
  • 4.4.1. Surgical Techniques Market, 2018 - 2030 (USD Billion)
  • 4.4.2. Hysterectomy
    • 4.4.2.1. Hysterectomy Market, 2018 - 2030 (USD Billion)
  • 4.4.3. Myomectomy
    • 4.4.3.1. Myomectomy Market, 2018 - 2030 (USD Billion)
• 4.5. Laparoscopic Techniques
  • 4.5.1. Laparoscopic Techniques Market, 2018 - 2030 (USD Billion)
  • 4.5.2. Laparoscopic Myotectomy
    • 4.5.2.1. Laparoscopic Myotectomy Market, 2018 - 2030 (USD Billion)
  • 4.5.3. Myolysis
    • 4.5.3.1. Myolysis Market, 2018 - 2030 (USD Billion)
• 4.6. Ablation Techniques
  • 4.6.1. Ablation Techniques Market, 2018 - 2030 (USD Billion)
  • 4.6.2. Microwave Ablation
    • 4.6.2.1. Microwave Ablation Market, 2018 - 2030 (USD Billion)
  • 4.6.3. Hydrothermal Ablation
    • 4.6.3.1. Hydrothermal Ablation Market, 2018 - 2030 (USD Billion)
  • 4.6.4. Cryoablation
    • 4.6.4.1. Cryoablation, 2018 - 2030 (USD Billion)
  • 4.6.5. Ultrasound Ablation
    • 4.6.5.1. Ultrasound Ablation Market, 2018 - 2030 (USD Billion)
    • 4.6.5.2. High Intensity Focused Ultrasound (HIFU)
      • 4.6.5.2.1. High Intensity Focused Ultrasound (HIFU) Market, 2018 - 2030 (USD Billion)
    • 4.6.5.3. MRI-guided Focused Ultrasound (MRgFUS)
      • 4.6.5.3.1. MRI-guided Focused Ultrasound (MRgFUS) Market, 2018 - 2030 (USD Billion)
• 4.7. Embolization Techniques
  • 4.7.1. Embolization Techniques Market, 2018 - 2030 (USD Billion)

Chapter 5. Uterine Fibroids Treatment Devices Market: Mode of Treatment Business Analysis

• 5.1. Mode of Treatment Market Share, 2024 & 2030
• 5.2. Mode of Treatment Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Mode of Treatment, 2018 to 2030 (USD Billion)
• 5.4. Invasive Treatment
  • 5.4.1. Invasive Treatment Market, 2018 - 2030 (USD Billion)
• 5.5. Minimally Invasive Treatment
  • 5.5.1. Minimally Invasive Treatment Market, 2018 - 2030 (USD Billion)
• 5.6. Non-invasive Treatment
  • 5.6.1. Non-invasive Treatment Market, 2018 - 2030 (USD Billion)

Chapter 6. Uterine Fibroids Treatment Devices Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework
    • 6.4.2.3. Competitive Insights
    • 6.4.2.4. U.S. Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework
    • 6.4.3.3. Competitive Insights
    • 6.4.3.4. Canada Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Framework
    • 6.4.4.3. Competitive Insights
    • 6.4.4.4. Canada Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.5. Europe
  • 6.5.1. Europe Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Insights
    • 6.5.2.4. UK Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Insights
    • 6.5.3.4. Germany Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Insights
    • 6.5.4.4. France Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework
    • 6.5.5.3. Competitive Insights
    • 6.5.5.4. Italy Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework
    • 6.5.6.3. Competitive Insights
    • 6.5.6.4. Spain Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.7. Norway
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework
    • 6.5.7.3. Competitive Insights
    • 6.5.7.4. Norway Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.8. Denmark
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework
    • 6.5.8.3. Competitive Insights
    • 6.5.8.4. Denmark Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.9. Sweden
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Regulatory Framework
    • 6.5.9.3. Competitive Insights
    • 6.5.9.4. Sweden Uterine Fibroids Treatment Devices Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 6.5.10. Russia
    • 6.5.10.1. Key Country Dynamics
    • 6.5.10.2. Regulatory Framework
    • 6.5.10.3. Competitive Insights
    • 6.5.10.4. Russia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Insights
    • 6.6.2.4. Japan Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Insights
    • 6.6.3.4. China Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Insights
    • 6.6.4.4. India Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Insights
    • 6.6.5.4. South Korea Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Insights
    • 6.6.6.4. Australia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Insights
    • 6.6.7.4. Thailand Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.7. Latin America
  • 6.7.1. Latin America Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. Brazil Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Argentina Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7.4. Colombia
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Regulatory Framework
    • 6.7.4.3. Competitive Insights
    • 6.7.4.4. Colombia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.8. MEA
  • 6.8.1. MEA Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. South Africa Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Saudi Arabia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. UAE Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Regulatory Framework
    • 6.8.5.3. Competitive Insights
    • 6.8.5.4. Kuwait Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Medtronic
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Technology Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Stryker
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Technology Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Boston Scientific Corporation
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Technology Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Insightec.
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Technology Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. CooperSurgical Inc.
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Technology Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Hologic, Inc.
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Technology Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. Lumenis Be Ltd
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Technology Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. CONMED Corporation.
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Technology Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. Gynesonics
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Technology Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. Merit Medical Systems.
    • 7.5.10.1. Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Technology Benchmarking
    • 7.5.10.4. Strategic Initiatives